Discoveries & Impact (January 2023)
Discoveries & Impact highlights select scientific discoveries across the Department of Internal Medicine...
Source: yale.edu
Mildly Reduced News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mildly Reduced. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mildly Reduced Today - Breaking & Trending Today
Forxiga (dapagliflozin) approved for symptomatic chronic heat failure
AstraZeneca today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a licence extension for dapagliflozin in Great Britain for the treatment of symptomatic chronic heart failure (HF) in patients with HF and a left ventricular ejection fraction (LVEF)
Source: news-medical.net
FARXIGA Significantly Reduced the Risk of Cardiovascular Death or Worsening of Heart Failure in Patients with Mildly Reduced or Preserved Ejection Fraction in DELIVER Phase III Trial
Data extend the clinically meaningful benefits of FARXIGA in patients with heart failure regardless of ejection fraction
Source: dicardiology.com
FARXIGA significantly reduced the risk of cardiovascular death or worsening of heart failure in patients with mildly reduced or preserved ejection fraction in DELIVER Phase III trial - Press Release
Results presented at European Society of Cardiology Congress 2022, and published in New England Journal of Medicine Data extend the clinically meaning
Source: wiredprnews.com